Safety and efficacy of the next generation of PI3K targeting agents reviewed @sabcs.bsky.social #SABCS24 poster highlights PS7-01-02-03 @oncoalert.bsky.social

For those wanting to optimize their care of premenopausal HR+ early breast cancer I highly recommend watching the #SABCS24 Educational Session “Mind the Gap Breast cancer in the young.” It really reinforces the importance of ovarian suppression! Tam is not enough in so many! #bcsm #OncSky #CanSky

T-Dxd approved as first line chemo in HR+, HER2 low or ultra low disease.

Do all patients need it first line?

Probably not. But great option for higher risk.

#bcsm #oncosky

Treatment Algorithm series: discussion on HER2+ #BreastCancer

✅ APT data/TCHP
✅ Metastatic disease
✅ Her2/ER/PR+

Full discussion:
⭐️ oncbrothers.com/her2positive...
⭐️ www.cancernetwork.com/treatment-al...
⭐️ “Oncology Brothers” podcast

#bcsm #CancerSky #OncSky

@drsarahsammons.bsky.social

Less than 2 months to #ASCO25! Join us to discuss the current SoC➕how the data from #ASCO25 will change/reinforce our practice!

⭐️ InPerson: May 31st, 2025
⭐️ Location📍Marriott Marquis
⭐️ Time: 6:30-9:00PM
⭐️ Register bit.ly/aioasco25

#AdvInOnc25 #OncSky

Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis academic.oup.com/oncolo/artic...
#SuppOnc #DatoDXd @hoperugo.bsky.social

Tonight at 7:30pm #YaleCancerAnswers host Dr. Eric Winer talks with Dr. Ann Partridge @danafarber.bsky.social about the care of young women with #breastcancer + ways to optimize knowledge and care to improve #cancer outcomes. #bcsm
🔹Listen live on WNPR
🔹Download on Apple Podcasts
🔹Watch on YouTube

A must read for Fertility Preservation in People With Cancer - Estelamari Rodriguez
@latinamd.bsky.social

oncodaily.com/science/2592...

#Cancer #CancerPatient #FertilityPreservation #CancerResearch #MedicalResearch #Medicine #Health #Oncology #OncoDaily

Targeting Menin: A New Frontier in Treating Refractory Leukemias #leusm #oncology www.onclive.com/view/targeti...